Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 1;51(4):e11-e13.
doi: 10.1097/OLQ.0000000000001942. Epub 2024 Jan 26.

Impact of Text-Based Monthly Check-Ins on Pre-Exposure Prophylaxis Retention at a Sexual Health Clinic

Kaitlin A Zinsli  1 , Meena S Ramchandani, Julia C Dombrowski, Chase A Cannon, Matthew R Golden, Cheryl Malinski  2 , Christine M Khosropour  1
Affiliations

Impact of Text-Based Monthly Check-Ins on Pre-Exposure Prophylaxis Retention at a Sexual Health Clinic

Kaitlin A Zinsli et al. Sex Transm Dis. .

Abstract

We conducted a retrospective cohort study of preexposure prophylaxis patients at the municipal Sexual Health Clinic in Seattle-King County, Washington from 2019 to 2021 to determine whether monthly check-in text messages impacted 4- and 6-month pre-exposure prophylaxis retention. Monthly check-ins did not appear to improve retention above and beyond open-ended texting and appointment reminders.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement M.S.R. received research funding from Nabriva unrelated to this work that has since ended. J.C.D. has conducted research with support from Hologic, Inc. and Mayne Pharmaceuticals. M.R.G. has received funding from both Hologic, Inc. and SpeeDx. C.M.K. has conducted research with support from Hologic, Inc. and Gilead Sciences.

References

    1. Marcus JL, Volk JE, Pinder J et al. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings. Curr HIV/AIDS Rep. 2016. Apr;13(2):116–24. - PubMed
    1. McCallister SM, Guzman R, Shcachko V et al., Gilead Sciences Inc. HIV-1 seroconversion across 17 international demonstration projects with pre-exposure prophylaxis (PrEP) with oral emtricitabine/tenofovir disoproxil fumarate (FTC/TDF). Interscience Conference on Antimicrobial Agents and Chemotherapy,; 2016.
    1. Fuchs JD, Stojanovski K, Vittinghoff E et al. A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis. AIDS Patient Care STDs. 2018. Mar;32(3):104–11. - PMC - PubMed
    1. Moore DJ, Jain S, Dubé MP et al. Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018. May 2;66(10):1566–72. - PMC - PubMed
    1. Liu AY, Vittinghoff E, von Felten P et al. Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019. May 30;68(12):2010–7. - PMC - PubMed